Schizophrenia and Disorders with Psychotic Features  >>  iloperidone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
iloperidone / Generic mfg.
NCT00254202: Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Completed
3
600
US, RoW
iloperidone, active comparator, placebo
Vanda Pharmaceuticals
Schizophrenia
09/06
03/07
REPRIEVE, NCT01291511: Relapse Prevention Study in Patients With Schizophrenia

Completed
3
635
US, RoW
Iloperidone, Fanapt®, Placebo
Vanda Pharmaceuticals
Schizophrenia
03/14
03/15

Download Options